Main laboratory abnormalities associated with COVID-19

Laboratory tests supporting clinicians in COVID-19 management

Numerous diagnostic parameters show abnormal laboratory results in COVID-19 patients. In addition to hematologic parameters, as lymphocyte count, especially CRP, LDH, Albumin as well as D-Dimer testing play a major role in monitoring and staging of COVID-19 patients.1,2,3 Close monitoring of selected analytes and timely interventions can significantly prevent severe outcomes and decrease mortality in COVID-19 patients.

COVID-19 related HUMAN products

* available for HumaCLIA 150

HUMAN´s portfolio covers all essential needs for reliable COVID-19 management comprising clinical chemistry, hematology and hemostasis diagnostic parameters as well as corresponding devices and analyzers.

You can find more detailed information here: 

References
1. Diagnosis and Treatment Protocol for Novel Coronavirus Pneumonia (Trial Version 7);Released by National Health Commission & State Administration of Traditional Chinese Medicine; March 3, 2020
2. Lippi G, Plebani M. Laboratory abnormalities in patients with COVID-2019 infection. Clin Chem Lab Med 2020 Feb 24., doi: 10.1515/cclm-2020-0198
3. Zhang et al. Risk Factors for Severe Disease and Efficacy of Treatment in Patients Infected With COVID-19:A Systematic Review, Meta-Analysis, and Meta-Regression Analysis. Clinical Infectious Diseases 2020;71(16):2199–206
4. Biochemical Monitoring of COVID-19 Patients - IFCC Information Guide on COVID-19, (Status: 18 Februar 2022) available from: www.ifcc.org/resources-downloads/ifcc-information-guide-on-covid-19-introduction/5-biochemical-monitoring-of-covid-19-patient